Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Stem Cell Exosomes for Osteoarthritis in Veterinary Medicine

Banu SA., Sharun K., Emmanuel RS., Mamachan M., Manjusha KM., Muthu S.

Narrative Review on Osteoarthritis, Cartilage Damage, published in Stem Cells Int (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Stem Cells Int (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40704321
PMCID
PMC12286686
DOI
10.1155/sci/4888569

Abstract (original English)

Osteoarthritis (OA) is a growing health concern worldwide. This disease is a major concern in human and veterinary patients, especially in growing and geriatric individuals. The poor regenerative capacity of damaged cartilage affects the healing process. Currently, no effective treatment strategy exists that provides a complete cure. Despite several traditional and pharmacological treatments, none of them resulted in the repair and regeneration of cartilage tissue. Regenerative therapy has gained increasing attention in the treatment of OA as it is directly involved in the regenerative process of damaged cartilage. The mesenchymal stem cells (MSCs) have therapeutic potential in treating OA resulting from their paracrine action on host cells, mediated via cytokines, exosomes, growth factors, and extracellular matrix molecules. Even though no significant side effects are documented, cell-based therapeutics could still present some risks. Exosomes, on the other hand, act primarily by channelizing the resident cells to restore the damaged cartilage and thus play an essential role in the treatment of OA. This review explores the regenerative efficacy of exosomes in managing OA in veterinary patients, elucidating their mechanisms of action and therapeutic potential. Recognizing the importance of comprehending exosomes and their mechanisms is crucial for developing safe and effective

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research